Northwestern Mutual Wealth Management’s MiNK Therapeutics INKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$190 Hold
18
﹤0.01% 3945
2025
Q4
$201 Sell
18
-1
-5% -$13 ﹤0.01% 3803
2025
Q3
$266 Hold
19
﹤0.01% 3682
2025
Q2
$140 Buy
19
+1
+6% +$8 ﹤0.01% 3536
2025
Q1
$156 Sell
18
-1
-5% -$9 ﹤0.01% 3474
2024
Q4
$132 Hold
19
﹤0.01% 3471
2024
Q3
$143 Hold
19
﹤0.01% 3465
2024
Q2
$181 Hold
19
﹤0.01% 3364
2024
Q1
$168 Hold
19
﹤0.01% 3407
2023
Q4
$198 Hold
19
﹤0.01% 3349
2023
Q3
$204 Hold
19
﹤0.01% 3177
2023
Q2
$389 Buy
+19
New +$381 ﹤0.01% 3191

Other funds holding INKT

Northwestern Mutual Wealth Management's INKT Position: Q1 2026 in Review

Northwestern Mutual Wealth Management held its MiNK Therapeutics (INKT) position steady in Q1 2026 at 18 shares worth $190. The position accounts for ﹤0.01% of the portfolio, ranked #3945.

Northwestern Mutual Wealth Management first reported a position in INKT in Q2 2023 and has held it in 12 quarters since. The position peaked at $389 in Q2 2023. 23 funds tracked by Wall St. Rank hold INKT as of Q1 2026.

  • Northwestern Mutual Wealth Management held 18 shares of MiNK Therapeutics worth $190 as of Q1 2026.
  • Northwestern Mutual Wealth Management left its MiNK Therapeutics share count unchanged in Q1 2026.
  • MiNK Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #3945 holding.
  • Northwestern Mutual Wealth Management first reported a position in MiNK Therapeutics in Q2 2023 and has held it in 12 quarters since.
  • Northwestern Mutual Wealth Management's MiNK Therapeutics position peaked at $389 in Q2 2023.
  • 23 funds tracked by Wall St. Rank held MiNK Therapeutics as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.